Search

everythinglearnresearchcommunity

for

Search:↓

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Systemic minoxidil is generally safe for older adults, but caution is needed for those with heart risks.

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

Spironolactone is effective and safe for treating acne in women, especially those over 25 with hormonal imbalances.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

Seresto® collar is safe to use with Advocate® and Profender® on dogs and cats.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Topical finasteride is an effective and safer treatment for male hair loss.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

CG2001 is safe and well-tolerated for treating hair loss in men.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.

Hair follicles are important for drug delivery through the skin, but better methods are needed to understand and improve this process.

Use of cosmeceuticals during pregnancy and breastfeeding is not recommended due to insufficient safety data.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Taking finasteride daily can effectively and safely increase hair density and thickness for women with hair loss.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.